Debt-to-equity of NKGen Biotech, Inc. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NKGen Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • NKGen Biotech, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was -126%, a 4.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 -126% +6.5% +4.9% 31 Mar 2025
Q4 2024 -126% +7.5% +5.6% 31 Dec 2024
Q3 2024 -128% +42% +25% 30 Sep 2024
Q2 2024 -133% -84% -173% 30 Jun 2024
Q1 2024 -133% -104% -356% 31 Mar 2024
Q4 2023 -134% -101% -312% 31 Dec 2023
Q3 2023 -169% -146% -624% 30 Sep 2023
Q2 2023 -49% -8.5% -21% 30 Jun 2023
Q1 2023 -29% +48% +62% 31 Mar 2023
Q4 2022 -32% 31 Dec 2022
Q3 2022 -23% 30 Sep 2022
Q2 2022 -40% 30 Jun 2022
Q1 2022 -77% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.